CLEAR

DEVICE3 trials

Sponsors

Pulmovant Inc., Ziemer Ophthalmic Systems AG

Conditions

AstigmatismMyopiaMyopic AstigmatismPulmonary Hypertension Associated with Interstitial Lung Disease

Phase 2

A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

Active, not recruitingCTIS2024-513991-16-00

Pulmovant Inc.Pulmonary Hypertension Associated with Interstitial Lung Disease

Start: 2025-01-17Target: 96Updated: 2025-11-24

Unknown Phase

Efficacy and Safety of CLEAR in Myopia and Astigmatism in Chinese Population

Ziemer Ophthalmic Systems AGMyopic Astigmatism

Start: 2021-11-29End: 2023-03-01Target: 215Updated: 2022-02-08

CLEAR Procedure in Myopia and Astigmatism - Registry Study

Ziemer Ophthalmic Systems AGAstigmatism, Myopia

Start: 2022-10-31End: 2024-04-30Target: 150Updated: 2022-08-02